Bnt162-17
Research payments
$9,814,413
Through program year 2025, $9,814,413 in research payments was reported against Bnt162-17, across 788 payments, paid by BioNTech SE.
- Paid by
- BioNTech SE
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $764,506 | 22 |
| 2024 | Research | $1,455,999 | 114 |
| 2022 | Research | $3,465,387 | 560 |
| 2021 | Research | $4,128,520 | 92 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Donald Brandon San Diego, CA Named on 91 payments
- Robert Falcone Whitehouse Station, NJ Named on 67 payments
- Douglas Denham San Antonio, TX Named on 54 payments
- Susann Varano New Haven, CT Named on 54 payments
- Matthew Davis Rochester, NY Named on 52 payments
- Robert Riesenberg Atlanta, GA Named on 43 payments
- Samir Arora Powell, OH Named on 42 payments
- Charles Andrews San Antonio, TX Named on 42 payments
- David Radin Stamford, CT Named on 36 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.